Satisfies New DEA Requirements for a one-time 8-hour SUD training for DEA registrants.

INTENSIVE COURSE IN PRESCRIBING AND PHARMACOLOGY OF CONTROLLED DRUGS: CURRENT ISSUES AND STRATEGIES FOR SUCCESSFUL PATIENT CARE
2023 SERIES FOR AUGUST AND NOVEMBER

Presented by the Medical Association of the State of Alabama and the Alabama Board of Medical Examiners.

Who Should Attend
The course in Prescribing and Pharmacology of Controlled Drugs is designed for physicians in all specialties, as well as physician assistants, certified registered nurse practitioners and nurse midwives, who need or wish to increase their knowledge and ability to effectively prescribe controlled medications that have the potential for misuse and abuse.

DEA-registered practitioners: This course qualifies to meet the DEA’s 8-hour training requirement for DEA-registered practitioners on the treatment and management of patients with opioid or other substance use disorders.

Statement of Need
Controlled drugs are being prescribed and dispensed at an increased rate to help patients cope with pain, anxiety, depression, insomnia, ADHD and myriad other disorders. Prescribing providers of controlled substances are faced with challenges in diagnosis and patient management across a spectrum of diverse patients and clinical settings. Controlled medications are unique in that they are frequently abused directly or through diversion. It is critical that prescribers be familiar with current practice guidelines and recommendations in order to stay up to date with best practices across an array of clinical scenarios. It is also important for the prescriber to continually improve their skills in caring for patients in practice settings that may not completely align with established guidelines, thereby calling for insight and professional judgment on how best to proceed. This activity will review cutting edge, best practice recommendations and guidelines across a variety of diagnostic and clinical settings that challenge the prescribing provider. These include clinical areas such as treatment of acute and chronic pain, identification and treatment of substance use disorders (especially prescription drug abusers), and addressing unique populations such as hospice patients.

Participant Learning Objectives
After attending this course, participants will be able to:
 Review the pathophysiological aspects of acute and chronic pain.
 Identify common psychosocial factors associated with chronic pain
 Recognize novel therapeutic approaches
 Discuss case management strategies in special situations, such as the elderly, hospice patients and renal sufficiency.
 Describe circumstances in which it is appropriate to refer a patient to a pain specialist.
 Recognize the need for early identification and the appropriate management for persons with psychiatric problems.
 Recognize the non-opioid approach to pharmacological treatment of post-operative pain.
 Define the eligibility requirements, rules, protocols, applications, and renewal processes required for PAs, CRNPs, and CNMs in a collaborative practice.
 Identify and construct an opioid treatment plan that will reduce the chances of prescription drug abuse and non-compliance.
 Describe the best practices for the treatment of opioid use disorder with Buprenorphine as a medication-assisted treatment.
 Recognize the symptoms of illicit drug use (i.e. methamphetamine, cocaine and heroin) and the potentially lethal impact when combined with synthetic opioids like fentanyl.
 Describe the common pharmacologic effect between each of the five families of controlled drugs.
 List three important factors in clinical decision-making regarding the long-term prescribing of benzodiazepines or psychostimulants.
 Recognize appropriate standards for prescribing controlled substances, use of risk and abuse mitigation strategies and circumstances when a prescribing license and registration are required.
 Identify the specific permissions and limitations of medical marijuana in Alabama.
 Describe permissible doses and formulations of marijuana in Alabama.
 Describe the limitations of operating a motor vehicle with regard to medical marijuana.

Faculty Information  (click here) 

FOR DATES AND DETAILS CLICK ON THE MEETING INFORMATION TAB.   

Registration Fees:
• $360.00 - Prescribing of Controlled Drugs (8 hours)
• $180.00 - Pharmacology of Controlled Drugs (4 hours)

Credit Designation and Accreditation Statements
The Medical Foundation of Alabama designates this live activity for a maximum of 12 AMA PRA Category 1 Credits ™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Medical Association of the State of Alabama through the joint providership of the Medical Foundation of Alabama and the Medical Association of the State of Alabama.  The Medical Foundation of Alabama is accredited by the Medical Association of the State of Alabama to provide continuing medical education for physicians.

Holders of an ACSC: Any two hours of the 12-hour Prescribing course meets the ALBME CME rule requiring holders of an ACSC to have, every two years, 2 AMA PRA Category 1 Credits™ of prescribing controlled substances.

Holders of a QACSC: The 12-hour Prescribing course is required for PAs, CRNPs, and CNMs to obtain a QACSC.  To renew a QACSC, PAs, CRNPs and CNMs must attend four hours of the twelve-hour Prescribing course, or any other Board-approved prescribing controlled substances course, every two years, listed at www.albme.gov/uploads/pdfs/ApprovedCMECourses.pdf

ABN CE Statement
• The Medical Association of the State of Alabama is an ABN-recognized provider of continuing education (CE). This course awards AMA PRA Category 1 Credits™ which may be used toward fulfillment of the pharmacology CE requirement for Advanced Practice approval/renewal.  ABN Administrative Code §§ 610-X-10-.01(2), 610-X-10-.02(5), 610-X-10-.04(2)(e)
• This course meets or exceeds the requirement for 6 hours of pharmacology CE required for renewal of Advanced Practice approval.
• To claim credit for this course, nurses must electronically upload the CME transcript issued by the Medical Association to his/her individual CE Record on the ABN website.   ABN Administrative Code § 610-X-10-.07(1)(d)


 REFUNDS
The deadline to cancel your registration and receive a 100% refund of the registration fee is two weeks before the activity date.  Cancellations must be received by the education department by e-mail and will not be accepted by telephone.  No refunds will be issued for no-shows and registration fees are non-transferrable.  Please send any cancellations to Lee Payne at lpayne@alamedical.org.

For More Information
Contact the Medical Association’s Education Department at (334) 954-2519.